The field of gene editing recently got a major boost from Massachusetts-based Beam Therapeutics, and the company’s Durham ...

Scientists have announced that they successfully maintained the function of a genetically modified pig liver for a brief ...

Base editing corrected a mutation that causes macular degeneration, highlighting the potential of gene therapy to treat ...

He Jiankui stands by a controversial research approach that landed him in prison as he aims to tackle Alzheimer’s disease.

Researchers from the J. Craig Venter Institute (JCVI), the Friedrich-Loeffler-Institut (FLI), and the International Livestock ...

A recent study estimates if ASFV reached the United States it could result in economic losses exceeding $50 billion over a ten-year period.

A Peninsula biotech company raised $68 million from investors — including a venture philanthropy fund started by Lululemon ...

The startup is using CRISPR tools to stop errant expression of a gene linked to facioscapulohumeral muscular dystrophy, a disorder on the radars of several drugmakers.

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS ® platform to develop in vivo gene editing therapies for high unmet need ...

A breakthrough in safely delivering therapeutic DNA to cells could transform treatment for millions suffering from common ...

Gene testing firm 23andMe has filed for bankruptcy. Here's what that means for people who have used their product and the ...

Expanding CRISPR's Potential Since its discovery, CRISPR (“Clustered Regularly Interspaced Short Palindromic Repeats”), which ...